Trends in the Assessment of Drug Supersaturation and Precipitation In Vitro Using Lipid-Based Delivery Systems.
暂无分享,去创建一个
[1] Shan Ren,et al. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs , 2010, The Journal of pharmacy and pharmacology.
[2] Martin Kuentz,et al. Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling , 2013, Pharmaceutical Research.
[3] M. Kuentz,et al. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life , 2012, Drug development and industrial pharmacy.
[4] Arik Dahan,et al. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[5] Christopher J. H. Porter,et al. Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway , 2013, Pharmaceutical Research.
[6] G. Amidon,et al. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. , 2011, Molecular pharmaceutics.
[7] M. Brewster,et al. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. , 2013, International journal of pharmaceutics.
[8] D. Mcclements,et al. New mathematical model for interpreting pH-stat digestion profiles: impact of lipid droplet characteristics on in vitro digestibility. , 2015 .
[9] K. Mäder,et al. Monitoring of In Vitro Fat Digestion by Electron Paramagnetic Resonance Spectroscopy , 2006, Pharmaceutical Research.
[10] Dallas B. Warren,et al. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products. , 2013, International journal of pharmaceutics.
[11] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] Martin Kuentz,et al. Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations. , 2014, Journal of pharmaceutical sciences.
[13] Christel A. S. Bergström,et al. Models for Predicting Drug Absorption From Oral Lipid-Based Formulations , 2015, Current Molecular Biology Reports.
[14] Thomas Rades,et al. In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate , 2014, The AAPS Journal.
[15] M. Khan,et al. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. , 2004, International journal of pharmaceutics.
[16] A. Hoffman,et al. Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.
[17] Ben J. Boyd,et al. Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.
[18] M. Khan,et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.
[19] P. Gao,et al. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.
[20] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.
[21] M. Khan,et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. , 2002, International journal of pharmaceutics.
[22] Dallas B. Warren,et al. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[23] F. Carrière,et al. In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14 , 2009, Pharmaceutical Research.
[24] M. Kuentz. Lipid-based formulations for oral delivery of lipophilic drugs. , 2012, Drug discovery today. Technologies.
[25] P. Gao,et al. Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. , 2010, Molecular pharmaceutics.
[26] A. Dahan,et al. The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs , 2012, The AAPS Journal.
[27] Christel A. S. Bergström,et al. Poorly soluble marketed drugs display solvation limited solubility. , 2007, Journal of medicinal chemistry.
[28] Ping Gao,et al. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. , 2009, Journal of pharmaceutical sciences.
[29] M. Kuentz,et al. Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects , 2011 .
[30] B. Griffin,et al. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.
[31] Mischa Bonn,et al. Label-free imaging of lipophilic bioactive molecules during lipid digestion by multiplex coherent anti-Stokes Raman scattering microspectroscopy. , 2010, Journal of the American Chemical Society.
[32] F. Carrière,et al. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.
[33] A. James. 2010 , 2011, Philo of Alexandria: an Annotated Bibliography 2007-2016.
[34] Thomas Rades,et al. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation. , 2016, Journal of pharmaceutical sciences.
[35] C. Pouton,et al. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations. , 2014, Molecular pharmaceutics.
[36] Patrick Augustijns,et al. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? , 2009, Journal of pharmaceutical sciences.
[37] Thomas Rades,et al. Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development , 2012, The AAPS Journal.
[38] R Holm,et al. Supersaturated Self-Nanoemulsifying Drug Delivery Systems (super-SNEDDS) , 2012 .
[39] Georgios Imanidis,et al. Advancing in‐vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model , 2011, The Journal of pharmacy and pharmacology.
[40] J. Reymond,et al. In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.
[41] Martin Kuentz,et al. Analytical technologies for real‐time drug dissolution and precipitation testing on a small scale , 2015, The Journal of pharmacy and pharmacology.
[42] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[43] Ulf Olsson,et al. Nucleation and crystal growth in supersaturated solutions of a model drug. , 2008, Journal of colloid and interface science.
[44] C. Pouton,et al. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[45] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[46] C. Pouton,et al. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. , 2009, Journal of pharmaceutical sciences.
[47] Christopher J H Porter,et al. Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.
[48] A. Müllertz,et al. In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. , 2011, International journal of pharmaceutics.
[49] J. Benneyan,et al. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[50] Thomas Rades,et al. Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System. , 2015, Molecular pharmaceutics.
[51] J. Reymond,et al. In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.
[52] Colin W Pouton,et al. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[53] B. Griffin,et al. Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[55] D. Kashchiev,et al. Review: Nucleation in solutions revisited , 2003 .
[56] C. Pouton,et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.
[57] Lynne S Taylor,et al. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. , 2014, Journal of pharmaceutical sciences.
[58] C. Porter,et al. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.
[59] Martin Kuentz,et al. Understanding interactions of oleic acid with basic drugs in solid lipids on different biopharmaceutical levels , 2014 .
[60] T. Rades,et al. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.
[61] Thomas Rades,et al. Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the Poorly Water-Soluble Drug Simvastatin in Dogs , 2012, The AAPS Journal.
[62] H. Kristensen,et al. A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[63] Ben J. Boyd,et al. Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.
[64] Christos Reppas,et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.
[65] Martin Kuentz,et al. Biopharmaceutical Modeling of Drug Supersaturation During Lipid-Based Formulation Digestion Considering an Absorption Sink , 2014, Pharmaceutical Research.
[66] G. Edwards,et al. In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[67] M. Kuentz,et al. Critical concentrations in the dilution of oral self-microemulsifying drug delivery systems , 2010, Drug development and industrial pharmacy.
[68] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.
[69] L. S. Taylor,et al. Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations , 2013 .
[70] A Müllertz,et al. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[71] A. Müllertz,et al. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations , 2013, Pharmaceutical Research.
[72] Selena Di Maio,et al. Effect of Ingested Lipids on Drug Dissolution and Release with Concurrent Digestion: A Modeling Approach , 2013, Pharmaceutical Research.
[73] G. Edwards,et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. , 2012, Molecular pharmaceutics.
[74] M. Kuentz,et al. Study of drug supersaturation for rational early formulation screening of surfactant/co‐solvent drug delivery systems , 2013, The Journal of pharmacy and pharmacology.
[75] M. Kuentz,et al. Application of a Statistical Method to the Absorption of a New Model Drug from Micellar and Lipid Formulations—Evaluation of Qualitative Excipient Effects , 2007, Pharmaceutical development and technology.
[76] K. Kawakami,et al. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. , 2012, Advanced drug delivery reviews.
[77] G. Edwards,et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.
[78] P. Gao,et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.
[79] G. Edwards,et al. Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.
[80] M. Kuentz,et al. A Systematic Dilution Study of Self-Microemulsifying Drug Delivery Systems in Artificial Intestinal Fluid Using Dynamic Laser Light Backscattering , 2009 .